BELLINI MICHELA

Ruolo: 
assegnista di ricerca

Pubblicazioni

  • Riva, B., Bellini, M., Corvi, E., Verderio, P., Rozek, E., Colzani, B., et al. (2018). Impact of the strategy adopted for drug loading in nonporous silica nanoparticles on the drug release and cytotoxic activity. JOURNAL OF COLLOID AND INTERFACE SCIENCE, 519, 18-26. Dettaglio
  • (2017). Development of apoferritin nanoparticles for chemotherapeutic delivery and drug resistance overcoming in breast cancer models. (Tesi di dottorato, Università degli Studi di Milano-Bicocca, 2017). Dettaglio
  • Mazzucchelli, S., Truffi, M., Baccarini, F., Beretta, M., Sorrentino, L., Bellini, M., et al. (2017). H-Ferritin-nanocaged olaparib: A promising choice for both BRCA-mutated and sporadic triple negative breast cancer. SCIENTIFIC REPORTS, 7(1). Dettaglio
  • Pandolfi, L., Bellini, M., Vanna, R., Morasso, C., Zago, A., Carcano, S., et al. (2017). H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells. BIOMACROMOLECULES, 18(10), 3318-3330. Dettaglio
  • Mazzucchelli, S., Bellini, M., Fiandra, L., Truffi, M., Rizzuto, M., Sorrentino, L., et al. (2017). Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity. ONCOTARGET, 8(5), 8383-8396. Dettaglio